Rare diseases
Investigational molecules
Locations
Back to France1 clinical trial in Vergèze, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Type 2 diabetes patients without prior cardiovascular events, exploring preventive strategies for heart-related complications.
This clinical investigation examines the effectiveness of combining colchicine and aspirin therapies to improve cardiovascular outcomes in high-risk diabetic patients. The research aims to establish new preventive approaches for protecting against serious cardiac events.
Advanced clinical research evaluating the potential of dual-therapy approaches in cardiovascular disease prevention for diabetic patients.
The study specifically focuses on evaluating how these interventions might reduce the risk of serious cardiovascular events, including heart attacks, strokes, and urgent cardiac procedures.
Comprehensive evaluation of cardiovascular outcomes in patients with diabetes, focusing on multiple cardiac endpoints.
This research examines various cardiovascular endpoints, including cardiac arrest, myocardial infarction, and stroke, while evaluating the effectiveness of preventive therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
